While we observed similar increases to the Ki67+ CD44hi CD8+ T cell population in the spleen as in the tumor, there was no increase in the frequency of NKG2D+ cells in M7824-treated mice (Fig. 5A, B). This evidence concerns the gene KLRK1 and neoplasm.